Hasaan Ahmed, Mahmoud Ismayl, Anirudh Palicherla, Anthony Kashou, Jalal Dufani, Andrew Goldsweig, Nandan Anavekar, Ahmed Aboeata
{"title":"既往无心房颤动病史患者的设备检测到的心房高频率发作的结果：系统回顾与元分析》。","authors":"Hasaan Ahmed, Mahmoud Ismayl, Anirudh Palicherla, Anthony Kashou, Jalal Dufani, Andrew Goldsweig, Nandan Anavekar, Ahmed Aboeata","doi":"10.15420/aer.2024.11","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Outcomes of device-detected AF remain unclear in individuals without a prior history of AF.</p><p><strong>Methods: </strong>A meta-analysis was conducted to evaluate outcomes in individuals with no prior history of AF who experienced device-detected AF. Outcomes assessed were clinical AF, thromboembolism and all-cause mortality. A fixed-effects model was used to calculate RRs with 95% CI.</p><p><strong>Results: </strong>Compared to individuals who did not experience device-detected AF, those who did had increased risks of clinical AF (RR 3.33, 95% CI [1.99.5.57]; p<0.0001) and thromboembolic events (RR 2.21; 95% CI [1.72.2.85]; p<0.0001). The risk of all-cause mortality was similar between both groups (RR 1.19; 95% CI [0.95.1.49]; p=0.13). Subgroup analysis revealed an increased risk of thromboembolic events among device-detected AF .24 hours (RR 12.34; 95% CI [2.70.56.36]).</p><p><strong>Conclusion: </strong>While there is an increased risk of clinical AF and thromboembolism in individuals with device-detected AF, mortality was insignificant.</p>","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":"13 ","pages":"e09"},"PeriodicalIF":2.6000,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11231819/pdf/","citationCount":"0","resultStr":"{\"title\":\"Outcomes of Device-detected Atrial High-rate Episodes in Patients with No Prior History of Atrial Fibrillation: A Systematic Review and Meta-analysis.\",\"authors\":\"Hasaan Ahmed, Mahmoud Ismayl, Anirudh Palicherla, Anthony Kashou, Jalal Dufani, Andrew Goldsweig, Nandan Anavekar, Ahmed Aboeata\",\"doi\":\"10.15420/aer.2024.11\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Outcomes of device-detected AF remain unclear in individuals without a prior history of AF.</p><p><strong>Methods: </strong>A meta-analysis was conducted to evaluate outcomes in individuals with no prior history of AF who experienced device-detected AF. Outcomes assessed were clinical AF, thromboembolism and all-cause mortality. A fixed-effects model was used to calculate RRs with 95% CI.</p><p><strong>Results: </strong>Compared to individuals who did not experience device-detected AF, those who did had increased risks of clinical AF (RR 3.33, 95% CI [1.99.5.57]; p<0.0001) and thromboembolic events (RR 2.21; 95% CI [1.72.2.85]; p<0.0001). The risk of all-cause mortality was similar between both groups (RR 1.19; 95% CI [0.95.1.49]; p=0.13). Subgroup analysis revealed an increased risk of thromboembolic events among device-detected AF .24 hours (RR 12.34; 95% CI [2.70.56.36]).</p><p><strong>Conclusion: </strong>While there is an increased risk of clinical AF and thromboembolism in individuals with device-detected AF, mortality was insignificant.</p>\",\"PeriodicalId\":8412,\"journal\":{\"name\":\"Arrhythmia & Electrophysiology Review\",\"volume\":\"13 \",\"pages\":\"e09\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-06-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11231819/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Arrhythmia & Electrophysiology Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15420/aer.2024.11\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arrhythmia & Electrophysiology Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/aer.2024.11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景：对于既往无房颤病史的患者，设备检测出房颤的结果仍不明确：方法：我们进行了一项荟萃分析，以评估既往无房颤病史但经历过设备检测房颤的患者的治疗效果。评估的结果包括临床房颤、血栓栓塞和全因死亡率。采用固定效应模型计算RRs和95% CI：结果：与没有经历过设备检测到房颤的人相比，经历过设备检测到房颤的人发生临床房颤的风险更高（RR 3.33，95% CI [1.99.5.57]；pCI）：虽然装置检测到房颤的患者发生临床房颤和血栓栓塞的风险会增加，但死亡率并不显著。
Outcomes of Device-detected Atrial High-rate Episodes in Patients with No Prior History of Atrial Fibrillation: A Systematic Review and Meta-analysis.
Background: Outcomes of device-detected AF remain unclear in individuals without a prior history of AF.
Methods: A meta-analysis was conducted to evaluate outcomes in individuals with no prior history of AF who experienced device-detected AF. Outcomes assessed were clinical AF, thromboembolism and all-cause mortality. A fixed-effects model was used to calculate RRs with 95% CI.
Results: Compared to individuals who did not experience device-detected AF, those who did had increased risks of clinical AF (RR 3.33, 95% CI [1.99.5.57]; p<0.0001) and thromboembolic events (RR 2.21; 95% CI [1.72.2.85]; p<0.0001). The risk of all-cause mortality was similar between both groups (RR 1.19; 95% CI [0.95.1.49]; p=0.13). Subgroup analysis revealed an increased risk of thromboembolic events among device-detected AF .24 hours (RR 12.34; 95% CI [2.70.56.36]).
Conclusion: While there is an increased risk of clinical AF and thromboembolism in individuals with device-detected AF, mortality was insignificant.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
